Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Mar 1, 2018, after the close
10-K filed Mar 16, 2018, 75 days after period end · 0001171843-18-002041
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $21.65M | $26.42M | $28.37M | $30.36M |
| Net Income | $999.00K | -$1.32M | -$17.14M | -$19.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| $0.03 |
| -$0.04 |
| -$0.51 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
